392 related articles for article (PubMed ID: 25910859)
1. Intestinal colonization with phylogenetic group B2 Escherichia coli related to inflammatory bowel disease: a systematic review and meta-analysis.
Petersen AM; Halkjær SI; Gluud LL
Scand J Gastroenterol; 2015; 50(10):1199-207. PubMed ID: 25910859
[TBL] [Abstract][Full Text] [Related]
2. High prevalence of Escherichia coli belonging to the B2+D phylogenetic group in inflammatory bowel disease.
Kotlowski R; Bernstein CN; Sepehri S; Krause DO
Gut; 2007 May; 56(5):669-75. PubMed ID: 17028128
[TBL] [Abstract][Full Text] [Related]
3. Dominant genotypes in mucosa-associated Escherichia coli strains from pediatric patients with inflammatory bowel disease.
Schippa S; Conte MP; Borrelli O; Iebba V; Aleandri M; Seganti L; Longhi C; Chiarini F; Osborn J; Cucchiara S
Inflamm Bowel Dis; 2009 May; 15(5):661-72. PubMed ID: 19067417
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of mucosa-associated diffusely adherent Escherichia coli in children with inflammatory bowel disease.
Walczuk U; Sobieszczańska B; Turniak M; Rzeszutko M; Duda-Madej A; Iwańczak B
Adv Clin Exp Med; 2019 Jul; 28(7):899-905. PubMed ID: 31066244
[TBL] [Abstract][Full Text] [Related]
5. Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease.
Iebba V; Conte MP; Lepanto MS; Di Nardo G; Santangelo F; Aloi M; Totino V; Checchi MP; Longhi C; Cucchiara S; Schippa S
Infect Immun; 2012 Apr; 80(4):1408-17. PubMed ID: 22290143
[TBL] [Abstract][Full Text] [Related]
6. [Presence of intracellular Escherichia coli in patients with inflammatory bowel disease].
De La Fuente M; Chahuán I; Gutiérrez R; Díaz-Jiménez D; Olivares M; Vidal R; Simian D; Figueroa C; Quera R; Hermoso MA
Rev Med Chil; 2017 Sep; 145(9):1129-1136. PubMed ID: 29424399
[TBL] [Abstract][Full Text] [Related]
7. Quantification and characterization of mucosa-associated and intracellular Escherichia coli in inflammatory bowel disease.
Elliott TR; Hudspith BN; Wu G; Cooley M; Parkes G; Quiñones B; Randall L; Mandrell RE; Fagerquist CK; Brostoff J; Rayment NB; Boussioutas A; Petrovska L; Sanderson JD
Inflamm Bowel Dis; 2013 Oct; 19(11):2326-38. PubMed ID: 23989750
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Escherichia coli isolated from gut biopsies of newly diagnosed patients with inflammatory bowel disease.
Sepehri S; Khafipour E; Bernstein CN; Coombes BK; Pilar AV; Karmali M; Ziebell K; Krause DO
Inflamm Bowel Dis; 2011 Jul; 17(7):1451-63. PubMed ID: 21674703
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the pathobiont adherent-invasive Escherichia coli and inflammatory bowel disease: a systematic review and meta-analysis.
Nadalian B; Yadegar A; Houri H; Olfatifar M; Shahrokh S; Asadzadeh Aghdaei H; Suzuki H; Zali MR
J Gastroenterol Hepatol; 2021 Apr; 36(4):852-863. PubMed ID: 32929762
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of Mucosa-Associated extended-spectrum β-Lactamase-producing Escherichia coli and Klebsiella pneumoniae among Iranain patients with inflammatory bowel disease (IBD).
Kharaghani AA; Harzandi N; Khorsand B; Rajabnia M; Kharaghani AA; Houri H
Ann Clin Microbiol Antimicrob; 2023 Sep; 22(1):86. PubMed ID: 37710309
[TBL] [Abstract][Full Text] [Related]
11. Escherichia coli Strains from Patients with Inflammatory Bowel Diseases have Disease-specific Genomic Adaptations.
Dubinsky V; Reshef L; Rabinowitz K; Wasserberg N; Dotan I; Gophna U
J Crohns Colitis; 2022 Nov; 16(10):1584-1597. PubMed ID: 35560165
[TBL] [Abstract][Full Text] [Related]
12. Genome-based Definition of an Inflammatory Bowel Disease-associated Adherent-Invasive Escherichia coli Pathovar.
Desilets M; Deng X; Rao C; Ensminger AW; Krause DO; Sherman PM; Gray-Owen SD
Inflamm Bowel Dis; 2016 Jan; 22(1):1-12. PubMed ID: 26444104
[TBL] [Abstract][Full Text] [Related]
13. Impaired Intestinal Permeability Contributes to Ongoing Bowel Symptoms in Patients With Inflammatory Bowel Disease and Mucosal Healing.
Chang J; Leong RW; Wasinger VC; Ip M; Yang M; Phan TG
Gastroenterology; 2017 Sep; 153(3):723-731.e1. PubMed ID: 28601482
[TBL] [Abstract][Full Text] [Related]
14. A phylogenetic group of Escherichia coli associated with active left-sided inflammatory bowel disease.
Petersen AM; Nielsen EM; Litrup E; Brynskov J; Mirsepasi H; Krogfelt KA
BMC Microbiol; 2009 Aug; 9():171. PubMed ID: 19695087
[TBL] [Abstract][Full Text] [Related]
15. The Prevalence of Adherent-Invasive
Kamali Dolatabadi R; Feizi A; Halaji M; Fazeli H; Adibi P
Front Med (Lausanne); 2021; 8():730243. PubMed ID: 34926490
[TBL] [Abstract][Full Text] [Related]
16. Escherichia coli B2 strains prevalent in inflammatory bowel disease patients have distinct metabolic capabilities that enable colonization of intestinal mucosa.
Fang X; Monk JM; Mih N; Du B; Sastry AV; Kavvas E; Seif Y; Smarr L; Palsson BO
BMC Syst Biol; 2018 Jun; 12(1):66. PubMed ID: 29890970
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of aggregative adherent Escherichia coli strains in the mucosa-associated microbiota of patients with inflammatory bowel diseases.
Thomazini CM; Samegima DA; Rodrigues MA; Victoria CR; Rodrigues J
Int J Med Microbiol; 2011 Aug; 301(6):475-9. PubMed ID: 21616711
[TBL] [Abstract][Full Text] [Related]
18.
Mirsepasi-Lauridsen HC; Vallance BA; Krogfelt KA; Petersen AM
Clin Microbiol Rev; 2019 Mar; 32(2):. PubMed ID: 30700431
[TBL] [Abstract][Full Text] [Related]
19. Overrepresentation of Enterobacteriaceae and
Khorsand B; Asadzadeh Aghdaei H; Nazemalhosseini-Mojarad E; Nadalian B; Nadalian B; Houri H
Front Cell Infect Microbiol; 2022; 12():1015890. PubMed ID: 36268225
[TBL] [Abstract][Full Text] [Related]
20. Specificities of the fecal microbiota in inflammatory bowel disease.
Sokol H; Seksik P; Rigottier-Gois L; Lay C; Lepage P; Podglajen I; Marteau P; Doré J
Inflamm Bowel Dis; 2006 Feb; 12(2):106-11. PubMed ID: 16432374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
